Impact of Early Low-Calorie Low-Protein Versus Standard Feeding on Outcomes of Ventilated Adults With Shock
NUTRIREA3
1 other identifier
interventional
3,044
2 countries
59
Brief Summary
Among critically ill patients requiring mechanical ventilation and catecholamines for shock, nearly 40% to 50% die, and functional recovery is often delayed in survivors. International guidelines include early nutritional support (≤48 h after admission), 20-25 kcal/kg/d at the acute phase, and 1.2-2 g/kg/d protein. These targets are rarely achieved in patients with severe critically illnesses. Recent data challenge the wisdom of providing standard amounts of calories and protein during the acute phase of critical illness. Studies designed to improve enteral nutrition delivery showed no outcome benefits with higher intakes. Instead, adding parenteral nutrition to increase intakes was associated with longer ICU stays and more infectious complications. Studies suggest that higher protein intakes during the acute phase may be associated with greater muscle wasting and ICU-acquired weakness. The optimal calorie and protein supply at the acute phase of severe critical illness remains unknown. NUTRIREA-3 will be the first trial to compare standard calorie and protein feeding complying with guidelines to low-calorie low-protein feeding potentially associated with improved muscle preservation, translating into shorter mechanical ventilation and ICU-stay durations, lower ICU-acquired infection rates, lower mortality, and better long-term clinical outcomes. This multicentre, randomized, controlled, open trial will compare, in patients receiving mechanical ventilation and treated with vasoactive agent for shock two strategies for initiating nutritional support at the acute phase of ICU management (D0-D7): early calorie/protein restriction (6 kcal/kg/d/0.2-0.4 g/kg/d, Low group) or standard calorie/protein targets (25 kcal/kg/d/1.0-1.3 g/kg/d, Standard group). Patients in both groups will receive enteral or parenteral nutrition appropriate for their critical illness. Two alternative primary end-points will be evaluated: all-cause mortality by day 90 and time to discharge alive from the ICU. Second end-points will be calories and proteins delivered, nosocomial infections, gastro-intestinal complications, glucose control, liver dysfunctions, muscle function at the time of readiness for ICU discharge and quality of life at 3 months and 1 year after study inclusion.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2018
Longer than P75 for not_applicable
59 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 7, 2018
CompletedFirst Posted
Study publicly available on registry
June 29, 2018
CompletedStudy Start
First participant enrolled
July 5, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 16, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 24, 2021
CompletedApril 6, 2022
April 1, 2022
2.5 years
June 7, 2018
April 5, 2022
Conditions
Outcome Measures
Primary Outcomes (2)
Time to discharge alive from the ICU.
A patient will be considered ready for ICU discharge by the bedside physicians as soon as all predefined clinical conditions for ICU discharge are fulfilled, regardless of ward-bed availability.
From date of ICU admission until the date of first documented date when predefined clinical conditions for ICU discharge are fulfilled, an average of 10 days.
D-90 mortality
All-cause mortality by day 90
90 days
Secondary Outcomes (31)
Number of calories (in kcal) delivered daily enterally and/or parenterally
from day 0 to day 7
Ratio of prescribed over calories delivered
from day 0 to day 7
Proportion of patients who achieved their calorie target
from day 0 to day 7
Protein supply
from day 0 to day 7
Volume of fluids
from day 0 to day 7
- +26 more secondary outcomes
Study Arms (2)
Low group
EXPERIMENTALPatients randomized in the "low group" will receive a low-calorie low-protein nutrition regimen during the acute phase.
Standard group
ACTIVE COMPARATORPatients randomized in the "standard group" will receive a standard-calorie/standard-protein nutrition regimen during the acute phase.
Interventions
In the low-calorie low-protein (Low) group, the calorie target will be 6 kcal/kg/day and the protein target 0.2-0.4 g/kg/d during the acute phase, i.e. from D0 to D7. On D8, the calorie target will be 30 kcal/kg/d and the protein target 1.2-2.0 g/kg/d.
In the standard-calorie/standard-protein (Standard) group, the first-line calorie target calculated based on body weight is 25 kcal/kg/day and the protein target 1.0-1.3 g/kg/d during the acute phase, i.e. from D0 to D7. On D8, the calorie target will be 30 kcal/kg/d and the protein target 1.2-2.0 g/kg/d.
Eligibility Criteria
You may qualify if:
- Treatment with a vasoactive agent for shock (adrenaline, dobutamine, or noradrenaline)
- Nutritional support expected to be started within 24 h after intubation or within 24 h after ICU admission when mechanical ventilation was started before ICU admission
- Age older than 18 years
You may not qualify if:
- Specific nutritional needs, such as pre-existing long-term home enteral or parenteral nutrition, for chronic bowel disease
- Dying patient, not-to-be-resuscitated order, or other treatment limitation decision at ICU admission
- Pregnancy, recent delivery, or lactation
- Adult under guardianship
- Department of corrections inmate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Nantes University Hospitallead
- Ministry of Health, Francecollaborator
- University Hospital, Tourscollaborator
Study Sites (59)
Chu de La Reunion Site Nord
Saint-Denis, La Réunion, 97405, France
Chu Amiens Picardie
Amiens, 80054, France
CHU Angers
Angers, 49100, France
Centre Hospitalier D'Angouleme
Angoulême, 16959, France
Ch Annecy-Genevois
Annecy, 74374, France
Centre Hospitalier D'Argenteuil
Argenteuil, 95100, France
Hôpital du bois brulé
Beauvais, 60000, France
Hôpital Nord Franche Comté
Belfort, 90015, France
Chu Jean Minjoz
Besançon, 25030, France
Hôpital de Béthune
Béthune, 62408, France
Hôpital Avicenne AP-HP
Bobigny, 93000, France
Hopital Pellegrin Chu
Bordeaux, 33000, France
CHU Cavale Blanche
Brest, 29609, France
Ch Chartres Louis Pasteur
Chartres, 28630, France
Chu Gabriel Montpied
Clermont-Ferrand, 63003, France
Hopital Louis Mourier (Ap-Hp)
Colombes, 92701, France
Ch Dieppe
Dieppe, 76202, France
Chu Bocage
Dijon, 21079, France
Hôpital Raymond-Poincaré
Garches, 92380, France
Hôpital Michalon
Grenoble, 38043, France
Chd Les Oudairies
La Roche-sur-Yon, 85025, France
Chu Bicetre
Le Kremlin-Bicêtre, 94270, France
Centre Hospitalier Du Mans
Le Mans, 72037, France
CH Emile Roux
Le Puy-en-Velay, 43000, France
Centre Hospitalier de Lens
Lens, 62300, France
Chr - Hopital Roger Salengro
Lille, 59037, France
CH Saint-Philibert
Lomme, 59462, France
Hopital de La Croix-Rousse
Lyon, 69317, France
Hopital Edouard Herriot
Lyon, 69437, France
Centre Hospitalier Marc Jacquet
Melun, 77011, France
Centre Hospitalier de Montauban
Montauban, 82013, France
Hopital Saint Eloi
Montpellier, 34295, France
Ctre Hosp Intercomm Andre Gregoire
Montreuil, 93100, France
Chu de Nantes
Nantes, 44000, France
CHU Nantes
Nantes, 44093, France
Chr D'Orleans
Orléans, 86709, France
Hopital Lariboisiere
Paris, 75010, France
Hôpital Saint Louis (AP-HP)
Paris, 75010, France
Hopital Saint Antoine
Paris, 75012, France
Hopital Pitie Salpetriere
Paris, 75013, France
CHU Paris Cochin
Paris, 75014, France
G.I.H. Bichat / Claude Bernard (Ap-Hp)
Paris, 75877, France
Hopital Europeen Georges Pompidou
Paris, 75908, France
CH Pau
Pau, 64000, France
Chu La Miletrie
Poitiers, 86021, France
C.H.R. Pontchaillou
Rennes, 35033, France
C.H. de Rodez Hopital Jacques Puel
Rodez, 12027, France
Hopital Charles Nicolle Chu Rouen
Rouen, 76038, France
CH Saint Brieuc
Saint-Brieuc, 22000, France
Ch General Delafontaine
Saint-Denis, 93205, France
CHU de Saint Etienne
Saint-Priest-en-Jarez, 42270, France
Hopital Broussais
St-Malo, 35403, France
Hôpital de Hautepierre CHU de Strasbourg
Strasbourg, 67098, France
Hopital Foch
Suresnes, 92150, France
CH de Bigorre
Tarbes, 65013, France
CHU DE TOURS Bretonneau
Tours, 37044, France
CH Valenciennes
Valenciennes, 59300, France
Centre Hospitalier Bretagne Atlantique - Vannes Auray
Vannes, 56017, France
CHU Pointe à Pitre - Abymes
Pointe-à-Pitre, 97159, Guadeloupe
Related Publications (2)
Reignier J, Plantefeve G, Mira JP, Argaud L, Asfar P, Aissaoui N, Badie J, Botoc NV, Brisard L, Bui HN, Chatellier D, Chauvelot L, Combes A, Cracco C, Darmon M, Das V, Debarre M, Delbove A, Devaquet J, Dumont LM, Gontier O, Groyer S, Guerin L, Guidet B, Hourmant Y, Jaber S, Lambiotte F, Leroy C, Letocart P, Madeux B, Maizel J, Martinet O, Martino F, Maxime V, Mercier E, Nay MA, Nseir S, Oziel J, Picard W, Piton G, Quenot JP, Reizine F, Renault A, Richecoeur J, Rigaud JP, Schneider F, Silva D, Sirodot M, Souweine B, Tamion F, Terzi N, Thevenin D, Thiery G, Thieulot-Rolin N, Timsit JF, Tinturier F, Tirot P, Vanderlinden T, Vinatier I, Vinsonneau C, Voicu S, Lascarrou JB, Le Gouge A; NUTRIREA-3 Trial Investigators; Clinical Research in Intensive Care; Sepsis (CRICS-TRIGGERSEP)Group. Low versus standard calorie and protein feeding in ventilated adults with shock: a randomised, controlled, multicentre, open-label, parallel-group trial (NUTRIREA-3). Lancet Respir Med. 2023 Jul;11(7):602-612. doi: 10.1016/S2213-2600(23)00092-9. Epub 2023 Mar 20.
PMID: 36958363DERIVEDReignier J, Le Gouge A, Lascarrou JB, Annane D, Argaud L, Hourmant Y, Asfar P, Badie J, Nay MA, Botoc NV, Brisard L, Bui HN, Chatellier D, Chauvelot L, Combes A, Cracco C, Darmon M, Das V, Debarre M, Delbove A, Devaquet J, Voicu S, Aissaoui-Balanant N, Dumont LM, Oziel J, Gontier O, Groyer S, Guidet B, Jaber S, Lambiotte F, Leroy C, Letocart P, Madeux B, Maizel J, Martinet O, Martino F, Mercier E, Mira JP, Nseir S, Picard W, Piton G, Plantefeve G, Quenot JP, Renault A, Guerin L, Richecoeur J, Rigaud JP, Schneider F, Silva D, Sirodot M, Souweine B, Reizine F, Tamion F, Terzi N, Thevenin D, Thiery G, Thieulot-Rolin N, Timsit JF, Tinturier F, Tirot P, Vanderlinden T, Vinatier I, Vinsonneau C, Maugars D, Giraudeau B. Impact of early low-calorie low-protein versus standard-calorie standard-protein feeding on outcomes of ventilated adults with shock: design and conduct of a randomised, controlled, multicentre, open-label, parallel-group trial (NUTRIREA-3). BMJ Open. 2021 May 11;11(5):e045041. doi: 10.1136/bmjopen-2020-045041.
PMID: 33980526DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jean Reignier, MD, PhD
Nantes University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 7, 2018
First Posted
June 29, 2018
Study Start
July 5, 2018
Primary Completion
December 16, 2020
Study Completion
December 24, 2021
Last Updated
April 6, 2022
Record last verified: 2022-04